AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37

Authors: WENDEL HP HELLER W MICHEL J MAYER G OCHSENFAHRT C GRAETER U SCHULZE J HOFFMEISTER HM HOFFMEISTER HE
Citation: Hp. Wendel et al., LOWER CARDIAC TROPONIN-T LEVELS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS AND RECEIVING HIGH-DOSE APROTININ THERAPY INDICATE REDUCTION OF PERIOPERATIVE MYOCARDIAL DAMAGE, Journal of thoracic and cardiovascular surgery, 109(6), 1995, pp. 1164-1172

Authors: HOFFMEISTER HM JUR M WENDEL HP HELLER W SEIPEL L
Citation: Hm. Hoffmeister et al., ALTERATIONS OF COAGULATION AND FIBRINOLYTIC AND KALLIKREIN-KININ SYSTEMS IN THE ACUTE AND POSTACUTE PHASES IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS, Circulation, 91(10), 1995, pp. 2520-2527

Authors: WENDEL HP HELLER W GALLIMORE MJ HOFFMEISTER HE
Citation: Hp. Wendel et al., HEPARIN-COATED OXYGENATORS SIGNIFICANTLY REDUCE CONTACT SYSTEM ACTIVATION IN AN IN-VITRO CARDIOPULMONARY BYPASS MODEL, Blood coagulation & fibrinolysis, 5(5), 1994, pp. 673-678

Authors: WENDEL HP HELLER W GALLIMORE MJ
Citation: Hp. Wendel et al., THE EFFECTS OF APROTININ ON CHROMOGENIC PEPTIDE SUBSTRATE AND OTHER ASSAYS FOR COMPONENTS OF THE COAGULATION, FIBRINOLYSIS AND PLASMA KALLIKREIN SYSTEMS, Fibrinolysis, 8(5), 1994, pp. 304-308

Authors: WENDEL HP HELLER W GALLIMORE MJ
Citation: Hp. Wendel et al., APROTININ IN THERAPEUTIC DOSES INHIBITS CHROMOGENIC PEPTIDE SUBSTRATEASSAYS FOR PROTEIN-C, Thrombosis research, 74(5), 1994, pp. 543-548

Authors: HELLER W WENDEL HP
Citation: W. Heller et Hp. Wendel, CLIVARIN(R) AND OTHER LMWHS IN AN EX-VIVO CARDIOPULMONARY BYPASS MODEL - STUDIES ON CONTACT ACTIVATION, Blood coagulation & fibrinolysis, 4, 1993, pp. 190000045-190000054

Authors: WENDEL HP HELLER W GALLIMORE MJ BANTEL H MULLERBEISSENHIRTZ H HOFFMEISTER HE
Citation: Hp. Wendel et al., INFLUENCE OF APROTININ ON DIFFERENT ACTIVATORS OF INTRINSIC COAGULATION PATHWAY IN THE PRESENCE OF ANTICOAGULANTS, Thrombosis and haemostasis, 69(6), 1993, pp. 626-626

Authors: HELLER W WENDEL HP PETERSDORFF T KLAFFSCHENKEL R HOFFMEISTER HE
Citation: W. Heller et al., COMPARISON BETWEEN LACTOBIONIC ACID AND HEPARIN ON COMPONENTS OF THE BLOOD DEFENSE SYSTEMS IN AN EX-VIVO CARDIOPULMONARY BYPASS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 670-670

Authors: HELLER W GALLIMORE MJ WENDEL HP HOFFMEISTER HE
Citation: W. Heller et al., INFLUENCE OF HEPARIN, HEPARIN PLUS APROTININ AND HIRUDIN ON CONTACT ACTIVATION IN A CARDIOPULMONARY BYPASS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 862-862

Authors: HELLER W WENDEL HP KLAFFSCHENKEL R HOFFMEISTER HE
Citation: W. Heller et al., POSSIBLE INTERACTION OF CORPUSCULAR AND PLASMATIC BLOOD COMPONENTS WITH HEPARIN-COATED ARTIFICIAL DEVICES DURING EXTRACORPOREAL-CIRCULATION, Thrombosis and haemostasis, 69(6), 1993, pp. 937-937

Authors: HELLER W WENDEL HP
Citation: W. Heller et Hp. Wendel, STUDIES IN HEPARIN-INDUCED ENDOTHELIUM AND PLATELET DAMAGE DURING EXTRACORPOREAL-CIRCULATION, Thrombosis and haemostasis, 69(6), 1993, pp. 1118-1118

Authors: WENDEL HP GALLIMORE MJ HELLER W
Citation: Hp. Wendel et al., APROTININ AND ITS EFFECTS ON CHROMOGENIC SUBSTRATE ASSAYS FOR SOME COMPONENTS OF THE PLASMA DEFENSE SYSTEMS, Thrombosis and haemostasis, 69(6), 1993, pp. 1270-1270
Risultati: 1-25 | 26-37 |